Industry Outlook
The cell expansion market is set to reach from US$ 9,743.7 Mn in 2018 to US$ 33,443.2 Mn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027. Lack of effective treatment regime for the chronic disease has resulted in significant rise in novel drug discovery and development research studies throughout the globe. Increasing demand for regenerative medicine and stem cell therapy further consolidates the cell expansion market growth.
"Significant rise in high throughput screening has resulted in increasing consumption of consumables during the novel drug discovery and development stage"
Consumables are reigning the products segment for cell expansion market. The chief contributing factor responsible for its positive market growth is significant rise in high throughput screening which increases the consumption of consumables during the novel drug discovery and development stage. Disposables will be growing at a rampant pace during the forecast period owing to negligible risk of cross contamination of laboratory equipments and flourishing biotechnology & pharmaceutical industry.
"Significant growth in translational research related to molecular biology and tissue engineering increases the demand for regenerative medicine"
Regenerative medicine is dominating the application segment for cell expansion market. In the last 2 decades there has been significant growth in translational research pertaining to molecular biology and tissue engineering. Regenerative medicine is widely employed in restoring normal function of cells and tissues of internal organs. Increasing demand for personalized medicine has created a lucrative market opportunity for the growth of regenerative medicine. Clinical diagnostics are garnering attention of researchers around the globe due to technological advancement in companion diagnostic kits and rising public health awareness resulting in early screening of chronic diseases.
"Rising prevalence of chronic disease and increasing demand for regenerative medicine together drive the market growth in North America"
North America with a market share of 35.2% is spearheading the regional segment for cell expansion market. The major factors influencing its market growth are rising prevalence of chronic disease. According to Center for Disease Control and Prevention (CDC), the statistics provided by National Health Council approximately 133 million Americans are suffering with chronic diseases. Tremendous demand for the development of regenerative medicine further propels the market growth in North America region. Europe represents a market share of 30.5% on account of domicile of major biopharmaceutical companies such as Becton Dickinson & Company, Merck Millipore, GE Healthcare etc. Asia Pacific presently holds 17.5% market share owing to the developing healthcare infrastructure and supportive regulatory environment provided by local healthcare agencies for the market proliferation of cell expansion products.
Historical & Forecast Period
This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027.
Report Scope by Segments
The market segmentation comprises of by product, application and geography.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2017-2027 |
Base Year | 2018 |
Forecast Period | 2019-2027 |
Historical Year | 2017 |
Unit | USD Million |
Segmentation |
By Product (2017–2027; US$ Mn) |
By Application (2017–2027; US$ Mn) |
|
Geography Segment (2017–2027; US$ Mn) |
Medical device companies spearheading the cell expansion market are Becton Dickinson & Company, Beckman Coulter, Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Miltenyi Biotec, STEMCELL Technologies, Terumo Biotec and Thermo Fisher Scientific.
Key questions answered in this report
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global CE Market Portraiture
2.2. Global CE Market, by Product, 2018 (US$ Mn)
2.3. Global CE Market, by Application, 2018 (US$ Mn)
2.4. Global CE Market, by Geography, 2018 (US$ Mn)
Chapter 3. Cell Expansion (CE) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global CE Market, by Key Players, 2018
Chapter 4. Global Cell Expansion (CE) Market, by Product
4.1. Overview
4.2. Instrument
4.3. Consumables
4.4. Disposables
Chapter 5. Global Cell Expansion (CE) Market, by Application
5.1. Overview
5.2. Regenerative Medicine
5.3. Cancer & Stem Cell Research
5.4. Clinical Diagnostics
5.5. Others
Chapter 6. Global Cell Expansion (CE) Market, by Geography
6.1. Overview
6.2. North America CE Market Analysis, 2017– 2027
6.2.1. North America CE Market, by Product, 2017 – 2027 (US$ Mn)
6.2.2. North America CE Market, by Application, 2017 – 2027 (US$ Mn)
6.2.3. North America CE Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe CE Market Analysis, 2017 – 2027
6.3.1. Europe CE Market, by Product, 2017– 2027 (US$ Mn)
6.3.2. Europe CE Market, by Application, 2017 – 2027 (US$ Mn)
6.3.3. Europe CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific CE Market Analysis, 2017 – 2027
6.4.1. Asia Pacific CE Market, by Product, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific CE Market, by Application, 2017– 2027 (US$ Mn)
6.4.3. Asia Pacific CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America CE Market Analysis, 2017 – 2027
6.5.1. Latin America CE Market, by Product, 2017 – 2027 (US$ Mn)
6.5.2. Latin America CE Market, by Application, 2017 – 2027 (US$ Mn)
6.5.3. Latin America CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa CE Market Analysis, 2017 – 2027
6.6.1. MEA CE Market, by Product, 2017 – 2027 (US$ Mn)
6.6.2. MEA CE Market, by Application, 2017 – 2027 (US$ Mn)
6.6.3. MEA CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Becton Dickinson & Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Beckman Coulter, Inc.
7.3. Corning Incorporation
7.4. Danaher Corporation
7.5. GE Healthcare
7.6. Merck Millipore
7.7. Miltenyi Biotec
7.8. STEMCELL Technologies
7.9. Terumo BCT
7.10. Thermo Fisher Scientific
* Here we are using CE as a short form of Cell Expansion
TABLE 1 Global Cell Expansion (CE) Market Portraiture
TABLE 2 Global CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 3 Global CE Market , by Application, 2017 – 2027 (US$ Mn)
TABLE 4 Global CE Market, by Geography, 2017 – 2027(US$ Mn)
TABLE 5 North America CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 6 North America CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 7 North America CE Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 9 Europe CE Market, by Application, 2017 – 2027(US$ Mn)
TABLE 10 Europe CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 13 Asia Pacific CE Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 14 Latin America CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa CE Market, by Product, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa CE Market, by Application, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa CE Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Becton Dickinson & Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Beckman Coulter, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Corning Incorporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Danaher Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Merck Millipore: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Miltenyi Biotec: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 STEMCELL Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Terumo BCT: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Thermo Fisher Scientific: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
FIG. 1 Cell Expansion (CE) Market: Research Methodology
FIG. 2 CE: Market Segmentation
FIG. 3 Global CE Market, by Product, 2018 (US$ Mn)
FIG. 4 Global CE Market, by Application, 2018 (US$ Mn)
FIG. 5 Global CE Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global CE Market, by Key Players, 2018
FIG. 8 Global Instrument CE Market, 2017 – 2027 (US$ Mn)
FIG. 9 Global Consumables CE Market, 2017– 2027 (US$ Mn)
FIG. 10 Global Disposables CE Market, 2017 – 2027 (US$ Mn)
FIG. 11 Global Regenerative Medicine Market for CE, 2017 – 2027 (US$ Mn)
FIG. 12 Global Cancer & Stem Cell Research Market for CE, 2017 – 2027 (US$ Mn)
FIG. 13 Global Clinical Diagnostics Market for CE, 2017 – 2027 (US$ Mn)
FIG. 14 Global Other Applications Market for CE, 2017 – 2027 (US$ Mn)
FIG. 15 U.S. CE Market, 2017 – 2027 (US$ Mn)
FIG. 16 Canada CE Market, 2017 – 2027 (US$ Mn)
FIG. 17 U.K. CE Market, 2017 – 2027 (US$ Mn)
FIG. 18 Germany CE Market, 2017– 2027 (US$ Mn)
FIG. 19 Rest of Europe CE Market, 2017 – 2027 (US$ Mn)
FIG. 20 China CE Market, 2017 – 2027 (US$ Mn)
FIG. 21 Japan CE Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest of Asia Pacific CE Market, 2017 – 2027 (US$ Mn)
FIG. 23 Brazil CE Market, 2017 – 2027 (US$ Mn)
FIG. 24 Mexico CE Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest of Latin America CE Market, 2017 – 2027 (US$ Mn)
FIG. 26 GCC CE Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest of MEA CE Market, 2017 – 2027 (US$ Mn)